BioLargo, Inc. Discusses Development and Scale-Up of Its PFAS Treatment Technology and 2022 Commercial Plans With The Stock Day Podcast (BLGO)

Phoenix, Arizona–(Newsfile Corp. – December 16, 2021) – The Stock Day Podcast welcomed BioLargo, Inc. (OTCQB: BLGO), a company that invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, wastewater treatment, and industrial odor and VOC control. President and CEO of BioLargo, Dennis P. Calvert, joined Stock Day host Everett Jolly for an interview.

Jolly began by asking about BioLargo’s consumer products strategic partnership with Ikigai Holdings. “Ikigai is a company that is focused on launching consumer products,” explained Calvert. “The partners at Ikigai have launched at least five blockbuster products in their careers,” he said, adding that they are “experts in the art of launching products that can build into a national brand.” He added, “We have bargained to be the supply chain partner. So, we’re wholesaling our product, earning a royalty on the technology, and then participating in a minority way on the exit.”

Jolly then asked about the progress of BioLargo’s Garratt-Callahan partnership. “Garratt-Callahan is the largest privately held water [treatment] company in America,” said Calvert. “We joined them as a technical expert to bring forth engineering and science to develop a product according to a design that they had created,” he explained. “That product is being tested now,” said Calvert. “We’re hoping to launch very early in 2022.”

The conversation then turned to the commercialization of BioLargo’s technology that eliminates per- and polyfluoroalkyl substances (PFAS), a class of water contaminants of rising concern because of their ubiquity in water around the world and their long-term health effects. “The Biden administration has listed [PFAS] as one of the top environmental issues of the decade,” said Calvert. “We have a device and expertise that provides selective extraction [of PFAS] … [It generates] 1/1000 the waste that’s created for disposal of the competition.”

The company hopes to get its PFAS treatment technology, called the Aqueous Electrostatic Concentrator, commercialized in 2022 in part by partnering with established players in the water treatment industry. “These projects could range [from] half a million all the way up to [the] fifteen million dollar range,” Calvert explained. “I think this is a huge opportunity for BioLargo to create value for our shareholders, so we are very excited.”

To hear Dennis Calvert’s entire interview, follow the link to the podcast here: https://audioboom.com/posts/7998255-biolargo-inc-discusses-development-and-scale-up-of-its-pfas-treatment-technology-and-2022-comme

Investors Hangout is a proud sponsor of “Stock Day,” and Stock Day Media encourages listeners to visit the company’s message board at https://investorshangout.com/

About BioLargo, Inc.

BioLargo, Inc. (OTCQB: BLGO) invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. With over 13 years of extensive R&D, BioLargo holds a wide array of issued patents, maintains a robust pipeline of products, and provides full-service environmental engineering. Our peer-reviewed scientific approach allows us to invent or acquire novel technologies and develop them to maturity through our operating subsidiaries. With a keen emphasis on collaborations with academic, municipal, and commercial organizations and associations, BioLargo has proven itself with over 80 awarded grants and numerous pilot projects. We monetize through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation and/or the sale of the IP. See our website at www.BioLargo.com.

Contact Information

Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863

Safe Harbor Act

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo’s (the “Company”) expectations regarding the impact of the COVID-19 pandemic; anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of the COVID-19 pandemic on the Company’s business, results of operations, financial condition, and stock price; the effect of regional economic conditions on the Company’s business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company’s products. More information on these risks and other potential factors that could affect the Company’s business and financial results is included in the Company’s filings with the SEC, including in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the Company’s most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.

About The “Stock Day” Podcast

Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America.

SOURCE:

Stock Day Media
(602) 821-1102